| # | Drug | Count |
|---|---|---|
| 0 | INSULIN GLARGINE | 4024 |
| 1 | INSULIN LISPRO | 2969 |
| 2 | METFORMIN | 1851 |
| 3 | METFORMIN ER 500 MG | 1851 |
| 4 | METFORMIN ER 750 MG | 1851 |
| 5 | DULAGLUTIDE | 1035 |
| 6 | INSULIN HUMAN | 921 |
| 7 | EXENATIDE | 730 |
| 8 | SITAGLIPTIN | 652 |
| 9 | INSULIN ASPART | 651 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INSULIN GLULISINE | 277 | 0.0271 |
| 1 | INSULIN LISPRO-AABC | 56 | 0.0266 |
| 2 | INSULIN HUMAN | 921 | 0.0231 |
| 3 | INSULIN LISPRO | 2969 | 0.0214 |
| 4 | INSULIN GLARGINE AND LIXISENATIDE | 71 | 0.0194 |
| 5 | EMPAGLIFLOZIN AND LINAGLIPTIN | 34 | 0.0173 |
| 6 | INSULIN GLARGINE | 4024 | 0.0161 |
| 7 | ALOGLIPTIN AND PIOGLITAZONE | 4 | 0.0161 |
| 8 | ERTUGLIFLOZIN | 17 | 0.0152 |
| 9 | LINAGLIPTIN AND METFORMIN HYDROCHLORIDE | 19 | 0.0150 |
| # | Drug class | Count |
|---|---|---|
| 0 | Insulin Analog [EPC] | 6734 |
| 1 | GLP-1 Receptor Agonist [EPC] | 2649 |
| 2 | Corticosteroid [EPC] | 1049 |
| 3 | Insulin [EPC] | 1029 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1026 |
| 5 | Sulfonylurea [EPC] | 881 |
| 6 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 781 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 653 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 638 |
| 9 | Atypical Antipsychotic [EPC] | 499 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 24 | 0.0349 |
| 1 | Insulin [EPC] | 1029 | 0.0222 |
| 2 | Insulin Analog [EPC] | 6734 | 0.0150 |
| 3 | Adrenocorticotropic Hormone [EPC] | 13 | 0.0145 |
| 4 | Leptin Analog [EPC] | 18 | 0.0143 |
| 5 | Provitamin D2 Compound [EPC] | 421 | 0.0141 |
| 6 | Catecholamine Synthesis Inhibitor [EPC] | 1 | 0.0123 |
| 7 | alpha-Glucosidase Inhibitor [EPC] | 53 | 0.0108 |
| 8 | Cortisol Synthesis Inhibitor [EPC] | 7 | 0.0093 |
| 9 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 248 | 0.0076 |